|  | 
| Effects of interruptions of radiotherapy on outcomes of patients with prostate cancer. | 
|  | 
|  | 
| No Relationships to Disclose | 
|  | 
|  | 
| No Relationships to Disclose | 
|  | 
|  | 
| No Relationships to Disclose | 
|  | 
|  | 
| No Relationships to Disclose | 
|  | 
|  | 
| Consulting or Advisory Role - New Century Health | 
|  | 
|  | 
| No Relationships to Disclose | 
|  | 
|  | 
| No Relationships to Disclose | 
|  | 
|  | 
| Honoraria - GlaxoSmithKline; Johnson & Johnson | 
| Consulting or Advisory Role - Myriad Genetics | 
| Speakers' Bureau - Janssen Oncology | 
|  | 
|  | 
| No Relationships to Disclose | 
|  | 
|  | 
| No Relationships to Disclose |